Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ventech in connection with investment in Freespee
Mandate

Vinge advises Ventech in connection with investment in Freespee

November 14, 2016

Ventech is a French venture capital investor and the investment in Freespee is Ventech’s first investment in the Nordic region.
Freespee makes it possible for marketers to monitor, handle and adapt the experience of customer communication. The company was established in 2009 and has offices in London, Paris, Barcelona and Sweden.

Vinge’s team consisted of responsible partner Christina Kokko together with, among others, Johan Mattsson and Matilda Gustafsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026